UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 25, 2006
------------
ROCKWELL MEDICAL TECHNOLOGIES, INC.
(Exact name of registrant as specified in its Charter)
Michigan 000-230-661 38-3317208
-------- ----------- ----------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
30142 Wixom Road, Michigan 48334
----------------- -------- -----
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (248) 960-9009
---------------------
Not applicable
------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.
On May 25, 2006, the shareholders of Rockwell Medical Technologies, Inc.
("Rockwell"), approved an amendment of the Rockwell Medical Technologies, Inc.
1997 Stock Option Plan (the "Plan") that increased the number of Rockwell common
shares with respect to which stock options may be granted under the Plan from
4,500,000 common shares to 4,750,000 common shares in the aggregate. Employees,
officers and directors of Rockwell are eligible to receive stock options under
the Plan.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(C) EXHIBITS.
The following exhibit is filed with this Form 8-K:
Exhibit Description
------- -----------
10.1 Rockwell Medical Technologies, Inc. 1997 Stock Option
Plan, incorporated by reference to Rockwell's Proxy
Statement for the Annual Meeting of Shareholders filed
with the Securities and Exchange Commission on April 17, 2006
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ROCKWELL MEDICAL TECHNOLOGIES, INC.
Date: May 26, 2006 By: /s/ Robert L. Chioini
--------------------------------------
Robert L. Chioini
President and Chief Executive Officer
EXHIBIT INDEX
Exhibit Description
------- -----------
10.1 Rockwell Medical Technologies, Inc. 1997 Stock Option Plan,
incorporated by reference to Rockwell's Proxy Statement for the
Annual Meeting of Shareholders filed with the Securities and
Exchange Commission on April 17, 2006